Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029
Clinical trial NCT00563810 · COMPLETED
Trial details
- NCT number
- NCT00563810
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.